Bizily Scott
Chief Legal Officer · 15 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | FDMT | 4D Molecular Therapeutics, Inc. | Sale | 6,566 | $14.00 | $91,924.00 | filing |
| 2026-06-30 | FDMT | 4D Molecular Therapeutics, Inc. | Option exercise | 5,752 | $6.49 | $37,330.48 | filing |
| 2026-06-30 | FDMT | 4D Molecular Therapeutics, Inc. | Option exercise | 814 | $4.14 | $3,369.96 | filing |
| 2026-06-23 | FDMT | 4D Molecular Therapeutics, Inc. | Sale | 9,810 | $12.00 | $117,720.00 | filing |
| 2026-06-23 | FDMT | 4D Molecular Therapeutics, Inc. | Option exercise | 9,810 | $4.14 | $40,613.40 | filing |
| 2025-12-16 | FDMT | 4D Molecular Therapeutics, Inc. | Sale | 1,635 | $10.90 | $17,821.50 | filing |
| 2025-12-16 | FDMT | 4D Molecular Therapeutics, Inc. | Option exercise | 1,635 | $4.14 | $6,768.90 | filing |
| 2025-11-17 | FDMT | 4D Molecular Therapeutics, Inc. | Sale | 1,635 | $10.59 | $17,314.65 | filing |
| 2025-11-17 | FDMT | 4D Molecular Therapeutics, Inc. | Option exercise | 1,635 | $4.14 | $6,768.90 | filing |
| 2025-10-24 | FDMT | 4D Molecular Therapeutics, Inc. | Sale | 2,678 | $12.00 | $32,136.00 | filing |
| 2025-10-24 | FDMT | 4D Molecular Therapeutics, Inc. | Option exercise | 1,084 | $6.49 | $7,035.16 | filing |
| 2025-10-16 | FDMT | 4D Molecular Therapeutics, Inc. | Sale | 1,635 | $10.17 | $16,627.95 | filing |
| 2025-10-16 | FDMT | 4D Molecular Therapeutics, Inc. | Option exercise | 1,635 | $4.14 | $6,768.90 | filing |
| 2025-10-09 | FDMT | 4D Molecular Therapeutics, Inc. | Sale | 2,408 | $10.00 | $24,080.00 | filing |
| 2025-09-23 | FDMT | 4D Molecular Therapeutics, Inc. | Sale | 2,407 | $8.00 | $19,256.00 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.